William R Shepard Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 5 days, 15 hours ago
William R Shepard has an estimated net worth of at least $50.5 million*, as of Jan. 1, 2025. They own 257,796 shares of CME stock. They have sold 0 shares of CME stock since 2021, for an estimated $-9.4 million.
William R Shepard $CME SEC Form 4 Insider Trading
William R Shepard has filed a total of 25 insider trades in $CME since 2021. Their most recent trade was a purchase of 264 shares, made on Dec 27, 2024. Their largest trade was a purchase of 40,000 shares, made on Nov 04, 2022. We estimate that they now own 257,796 shares of $CME, worth an estimated $59.9 million.
Insider Trading at $CME
There have been a total of 118 insider trades reported at $CME since 2021, with 57,711 shares purchased and 253,948 shares sold. The most active insider traders in $CME stock have been Terrence A Duffy, Hilda Harris Piell, and Timothy Francis Mccourt. The most recent trade was a purchase of 11 shares reported by WILLIAM R SHEPARD (None), made on Dec 27, 2024.
History of Insider Stock Trades by William R Shepard
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
CME | Purchase | 264 | Dec 27, 2024 | Dec. 30, 2024, 5:49 p.m. |
CME | Purchase | 11 | Dec 27, 2024 | Dec. 30, 2024, 5:49 p.m. |
CME | Purchase | 12 | Sep 25, 2024 | Sept. 27, 2024, 11:43 a.m. |
CME | Purchase | 280 | Sep 25, 2024 | Sept. 27, 2024, 11:43 a.m. |
CME | Purchase | 13 | Jun 25, 2024 | June 26, 2024, 8:48 p.m. |
CME | Purchase | 312 | Jun 25, 2024 | June 26, 2024, 8:48 p.m. |
CME | Purchase | 12 | Mar 26, 2024 | March 27, 2024, 12:49 p.m. |
CME | Purchase | 282 | Mar 26, 2024 | March 27, 2024, 12:49 p.m. |
CME | Purchase | 1,331 | Jan 18, 2024 | Jan. 19, 2024, 6:03 p.m. |
CME | Purchase | 58 | Jan 18, 2024 | Jan. 19, 2024, 6:03 p.m. |
CME | Purchase | 266 | Dec 28, 2023 | Dec. 29, 2023, 4:31 p.m. |
CME | Purchase | 11 | Dec 28, 2023 | Dec. 29, 2023, 4:31 p.m. |
CME | Purchase | 12 | Sep 27, 2023 | Oct. 6, 2023, 9:47 a.m. |
CME | Purchase | 279 | Sep 27, 2023 | Oct. 6, 2023, 9:47 a.m. |
CME | Purchase | 308 | Jun 27, 2023 | June 28, 2023, 2:39 p.m. |
CME | Purchase | 13 | Jun 27, 2023 | June 28, 2023, 2:39 p.m. |
CME | Purchase | 297 | Mar 27, 2023 | March 29, 2023, 7:28 p.m. |
CME | Purchase | 13 | Mar 27, 2023 | March 29, 2023, 7:28 p.m. |
CME | Purchase | 194 | Mar 28, 2023 | March 29, 2023, 7:28 p.m. |
CME | Purchase | 12 | Dec 28, 2022 | Jan. 20, 2023, 5:41 p.m. |
CME | Purchase | 289 | Dec 28, 2022 | Jan. 20, 2023, 5:41 p.m. |
CME | Purchase | 54 | Jan 18, 2023 | Jan. 20, 2023, 5:41 p.m. |
CME | Purchase | 1,243 | Jan 18, 2023 | Jan. 20, 2023, 5:41 p.m. |
CME | Purchase | 40,000 | Nov 04, 2022 | Nov. 8, 2022, 8:28 p.m. |
CME | Purchase | 8,645 | Nov 04, 2022 | Nov. 8, 2022, 8:28 p.m. |
$CME Executives and Stock Owners with Insider Trades
-
Terrence A Duffy, Chairman and CEO
-
Hilda Harris Piell, Sr MD & Chief HR Officer
-
Timothy Francis Mccourt, Sr MD Global Head Equity & FX
-
Derek Sammann, Sr MD Gl Hd Commodity & Option
-
Kevin Kometer, Sr MD Chief Information Office
-
Sean Tully, Sr MD Global Hd Financial & OT
-
Sunil Cutinho, Chief Information Officer
-
Julie Holzrichter, Sr MD Chief Operating Officer
-
Julie Winkler, Sr MD Chief Commercial Officer
-
Kathleen M Cronin, Sr MD Gen Counsel & Corp Secr
-
Ken Vroman, Chief Transformation Officer
-
Ken Vroman, Sr MD International & Optimiza
-
Lynne Fitzpatrick, Sr MD Chief Financial Officer
-
Sunil Cutinho, Sr MD & President CME Clearing
-
Suzanne Sprague, Sr MD Global Head of Clearing
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.